|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01931 IVD MEDICAL
Nominal 
1.800 +0.070 (+4.046%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 1,353,470 | -1.731% | 1,377,314 | 1,176,557 | 1,186,791 | 981,240 |
| Cost of Sales | (1,028,778) | -4.369% | (1,075,774) | (910,134) | (946,902) | (787,061) |
| Gross Profit | 324,692 | 7.678% | 301,540 | 266,423 | 239,889 | 194,179 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (6) | -99.636% | (1,648) | (6,981) | 170 | 386 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (3,919) | -69.364% | (12,792) | 345 | 284 | 188 | |
| Profit / (Loss) before Taxation | 180,491 | 10.793% | 162,909 | 103,495 | 118,958 | 60,353 | |
| Taxation | (52,925) | -10.155% | (58,907) | (33,794) | (41,597) | (24,261) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,278) | 129.406% | (993) | 11,448 | 1,526 | 2,189 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 125,288 | 21.628% | 103,009 | 81,149 | 78,887 | 38,281 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,863 | 9.711% | 8,990 | 11,017 | 8,218 | 10,999 |
| Depreciation & Amortisation | 19,682 | 8.048% | 18,216 | 20,016 | 18,784 | 17,913 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 9.270 | 21.654% | 7.620 | 6.070 | 5.960 | 2.870 |
| DPS (cts) | 0.000 | -- | 2.732 | 2.372 | 2.219 | 1.495 |
| Dividend Payout Ratio (%) | -- | -- | 35.854% | 39.074% | 37.223% | 52.074% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.505 | -- | 2.364 | 2.243 | 2.142 | 2.117 |
| Remarks: | Real time quote last updated: 20/09/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 125,288 |
| %Change | 21.628% |
| EPS / (LPS) | RMB 0.093 |
| NBV Per Share (¥) | RMB 2.505 |